General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
0 |
06/08/25 |
06/08/25 |
General
|
13K
|
5.1M
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
0 |
06/08/25 |
06/08/25 |
General
|
13K
|
5.1M
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Who has been selling and why?
|
|
NTinvest
|
6 |
1.9K |
0 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
6
|
1.9K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Who has been selling and why?
|
|
NTinvest
|
6 |
1.9K |
2 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
6
|
1.9K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
0 |
05/08/25 |
05/08/25 |
General
|
13K
|
5.1M
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
1 |
05/08/25 |
05/08/25 |
General
|
13K
|
5.1M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
1 |
05/08/25 |
05/08/25 |
General
|
13K
|
5.1M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Phase 2 Bisantrene AML Trial Results Published
|
|
NTinvest
|
65 |
20K |
5 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
65
|
20K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: June 2025 Quarterly Activity Report and Appendix 4C
|
|
NTinvest
|
136 |
36K |
4 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
136
|
36K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
NTinvest
|
3.1K |
1.1M |
3 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
3.1K
|
1.1M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
NTinvest
|
13K |
5.1M |
7 |
21/07/25 |
21/07/25 |
General
|
13K
|
5.1M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Upcoming 2025 Investor Events
|
|
NTinvest
|
56 |
17K |
2 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
56
|
17K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
0 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
3 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
3 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
4 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
3 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
2 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
3 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
2 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
5 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
5 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
262
|
76K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial
|
|
NTinvest
|
262 |
76K |
1 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
262
|
76K
|
1
|
|